News
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...
Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...
Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
People with diabetes who used semaglutide or other GLP-1 agonists were also less likely to see a provider for depression.
According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.
Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its 2025-26 budget plans.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results